• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

    2/7/23 4:15:54 PM ET
    $TALK
    Medical/Nursing Services
    Health Care
    Get the next $TALK alert in real time by email
    SC 13D/A 1 d342824dsc13da.htm SC 13D/A SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)

     

     

    TALKSPACE, INC.

    (Name of Issuer)

    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

    87427V103

    (CUSIP Number)

    Paul Conway

    Chief Financial Officer

    Spark Management Partners IV, LLC

    200 Clarendon Street, Floor 59

    Boston, MA 02116

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    August 11, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ☐.

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on following pages)

     

     

     


    CUSIP No. 87427V103    13D            

     

      1    

      NAMES OF REPORTING PERSONS

     

      Spark Management Partners IV, LLC

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     

      (a)  ☐        (b)  ☒

      3  

      SEC USE ONLY

     

      4  

      SOURCE OF FUNDS (see instructions)

     

      AF

      5  

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

      ☐

      6  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7    

      SOLE VOTING POWER

     

      0

         8  

      SHARED VOTING POWER

     

      7,716,545 (1)

         9  

      SOLE DISPOSITIVE POWER

     

      0

       10  

      SHARED DISPOSITIVE POWER

     

      7,716,545 (1)

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      7,716,545 (1)

    12  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

      ☐

    13  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

      4.8% (2)

    14  

      TYPE OF REPORTING PERSON (see instructions)

     

      OO

     

    (1)

    All shares are held of record by Spark IV and Spark FF IV (each, as defined in Item 2(a) of the Original Schedule 13D (as defined below)). Spark IV GP (as defined in Item 2(a) of the Original Schedule 13D) is the general partner of each of Spark IV and Spark FF IV and may be deemed to have voting, investment and dispositive power with respect to these securities.

    (2)

    Based on 159,149,884 shares of Common Stock outstanding as of November 4, 2022, as reported by the Issuer in its Form 10-Q for quarter ended September 30, 2022 and filed with the United States Securities and Exchange Commission on November 8, 2022 (the “Form 10-Q”).


    CUSIP No. 87427V103    13D            

     

      1    

      NAMES OF REPORTING PERSONS

     

      Spark Capital IV, L.P.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     

      (a)  ☐        (b)  ☒

      3  

      SEC USE ONLY

     

      4  

      SOURCE OF FUNDS (see instructions)

     

      WC

      5  

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

      ☐

      6  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7    

      SOLE VOTING POWER

     

      0

         8  

      SHARED VOTING POWER

     

      7,640,925 (1)

         9  

      SOLE DISPOSITIVE POWER

     

      0

       10  

      SHARED DISPOSITIVE POWER

     

      7,640,925 (1)

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      7,640,925 (1)

    12  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

      ☐

    13  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

      4.8% (2)

    14  

      TYPE OF REPORTING PERSON (see instructions)

     

      PN

     

    (1)

    All shares are held of record by Spark IV. Spark IV GP is the general partner of Spark IV and may be deemed to have voting, investment and dispositive power with respect to these securities.

    (2)

    Based on 159,149,884 shares of Common Stock outstanding as of November 4, 2022, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 87427V103    13D            

     

      1    

      NAMES OF REPORTING PERSONS

     

      Spark Capital Founders’ Fund IV, L.P.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     

      (a)  ☐        (b)  ☒

      3  

      SEC USE ONLY

     

      4  

      SOURCE OF FUNDS (see instructions)

     

      WC

      5  

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

      ☐

      6  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7    

      SOLE VOTING POWER

     

      0

         8  

      SHARED VOTING POWER

     

      75,620 (1)

         9  

      SOLE DISPOSITIVE POWER

     

      0

       10  

      SHARED DISPOSITIVE POWER

     

      75,620 (1)

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      75,620 (1)

    12  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

      ☐

    13  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

     

      0.0% (2)

    14  

      TYPE OF REPORTING PERSON (see instructions)

     

      PN

     

    (1)

    All shares are held of record by Spark FF IV. Spark IV GP is the general partner of Spark FF IV and may be deemed to have voting, investment and dispositive power with respect to these securities.

    (2)

    Based on 159,149,884 shares of Common Stock outstanding as of November 4, 2022, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 87427V103    13D            

     

    Explanatory Note:

    This Amendment No. 1 (this “Amendment”) amends and supplements the Schedule 13D originally filed by the Reporting Persons with the United States Securities and Exchange Commission (the “SEC”) on July 2, 2021 (the “Original Schedule 13D”). Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13D remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment have the meanings ascribed to them in the Original Schedule 13D.

    Item 2. Identity and Background.

    (b) The business address of each Reporting Person is 200 Clarendon Street, Floor 59, Boston, MA 02116.

    Item 5. Interest in Securities of the Issuer.

    Solely on behalf of, and only to the extent that it relates to the Reporting Persons, Item 5 of the Original Schedule 13D is hereby amended as follows:

    (a) and (b) See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person. The information reported on such cover pages is reported as of December 31, 2022.

    (c) The Reporting Persons effected sale transactions on most business days from July 18, 2022 through December 31, 2022, selling an average of 42,096 shares of Common Stock at an average price per share of $1.10 (in the aggregate across all Reporting Persons) on each such business day in which it engaged in such transactions. The range of sales prices was a minimum of $0.57/share and a maximum of $1.89/share. The Reporting Persons did not purchase any shares of Common Stock during such period. The Reporting Persons have continued to engage in sale transactions after December 31, 2022 through the date of the filing of this statement. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the date of each such transaction, the number of shares of Common Stock sold by each Reporting Person in each such transaction, the price per share of each such sale, and where and how each such transaction was effected.

    (e) Each of the Reporting Persons ceased to be a beneficial owner of more than five percent of the Issuer’s securities as of December 12, 2022.


    CUSIP No. 87427V103    13D            

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 7, 2023

     

    SPARK CAPITAL IV, L.P.
    By:   SPARK MANAGEMENT PARTNERS IV, LLC
    Its:   General Partner
    By:   /s/ Paul Conway
      Paul Conway, Managing Member
    SPARK CAPITAL FOUNDERS’ FUND IV, L.P.
    By:   SPARK MANAGEMENT PARTNERS IV, LLC
    Its:   General Partner
    By:   /s/ Paul Conway
      Paul Conway, Managing Member
    SPARK MANAGEMENT PARTNERS IV, LLC
    By:   /s/ Paul Conway
      Paul Conway, Managing Member
    Get the next $TALK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TALK

    DatePrice TargetRatingAnalyst
    4/3/2025$5.00Buy
    Canaccord Genuity
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    12/4/2024$5.00Outperform
    Mizuho
    11/20/2024$5.00Outperform
    Northland Capital
    7/1/2024Hold
    Needham
    1/3/2024$2.50Equal Weight
    Barclays
    12/2/2021$2.00Hold
    Jefferies
    11/16/2021$10.00 → $3.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

      SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

      2/14/24 4:24:23 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

      SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

      2/9/24 7:24:33 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

      SC 13D/A - Talkspace, Inc. (0001803901) (Subject)

      10/5/23 6:41:35 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Financials

    Live finance-specific insights

    See more
    • Talkspace Announces First Quarter 2025 Results

      1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

      5/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace to Report First Quarter 2025 Results and Host Conference Call

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that it will release its first quarter 2025 results on Tuesday, May 6, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and referencing participant code 1021845. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About Talkspace

      4/16/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Announces Fourth Quarter and Full Year 2024 Results

      Full year 2024 total revenue grew 25% year-over-year to $187.6 millionFull year 2024 net income of $1.1 million and adjusted EBITDA1 of $7.0 million 4Q 2024 total revenue grew 15% year-over-year to $48.7 million4Q 2024 net income of $1.2 million and adjusted EBITDA1 of $2.7 million NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported fourth quarter and full year 2024 financial results.     Three Months Ended December 31, 2024 Year Ended December 31, 2024     Unaudited Results % Variance from Prior Year Results % Variance from Prior Year(In thousands unless otherwise noted)        Number of eligible lives at ye

      2/20/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Harris Ian Jiro bought $86,037 worth of shares (30,844 units at $2.79), increasing direct ownership by 5% to 615,015 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/5/25 4:00:06 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/3/25 9:30:03 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Legal Officer, Secretary Reilly John Charles bought $10,242 worth of shares (3,600 units at $2.85), increasing direct ownership by 0.41% to 889,806 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      2/28/25 9:55:04 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Talkspace to Participate in Upcoming Investor Conferences

      NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the following upcoming investor conferences: The Truist Healthcare Disruptors & Digital Health Conference, being held in New York, including 1x1 meetings with investors on Tuesday, June 24, 2025, and a panel discussion on "Addressing the Mental Health Crisis" with Chief Executive Officer, Dr. Jon Cohen, on Wednesday, June 25, 2025 at 2:40pm ET.The Northland Growth Conference, being held virtually, including 1x1 meetings with investors on Wednesday, June 25, 2025. About Talkspace Talkspace (NASDAQ:TALK) is a le

      6/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Becomes First Behavioral Health Provider to Integrate with Amazon Pharmacy, Offering Psychiatry Services and a More Seamless Medication Management Experience

      Amazon Pharmacy now streamlines medication fulfillment for Talkspace members. Talkspace (NASDAQ:TALK), a leading online behavioral health company, today announced a new collaboration with Amazon Pharmacy to simplify the pharmacy experience for Talkspace members and streamline medication management and adherence support for providers. Mental health medication adherence remains a significant challenge in the U.S., with adherence rates ranging between 45% and 55% for many common conditions. Cost and access are two of the most persistent barriers. A study published in JAMA Psychiatry found that 21% of individuals with depression did not fill a prescribed medication in the past year due to c

      5/29/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Navigate Drives Continued Momentum in its Partner Ecosystem; Adds Talkspace, movr, and Springbuk

      WEST DES MOINES, Iowa, May 7, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced strategic partnerships with Talkspace (NASDAQ:TALK), movr, and Springbuk, adding significant strength to its partner ecosystem. These leading solutions address three of the most urgent and costly areas in workforce health: mental health, musculoskeletal (MSK) care, and population health intelligence. "Employers are no longer willing to take a trial-and-error approach to employee health benefits," stated Troy Vincent, Founder and CEO of Navigate Wellbeing Solutions. "Our wellbeing solution

      5/7/25 11:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity initiated coverage on Talkspace with a new price target

      Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

      4/3/25 8:18:33 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Talkspace with a new price target

      KeyBanc Capital Markets initiated coverage of Talkspace with a rating of Overweight and set a new price target of $4.50

      12/9/24 8:34:29 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Mizuho initiated coverage on Talkspace with a new price target

      Mizuho initiated coverage of Talkspace with a rating of Outperform and set a new price target of $5.00

      12/4/24 7:49:48 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Technology Officer Margolin Gil exercised 3,516 shares at a strike of $0.88 and sold $11,392 worth of shares (3,516 units at $3.24) (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/5/25 9:30:47 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Director Braunstein Douglas L was granted 5,757 shares, increasing direct ownership by 0.29% to 2,019,645 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/3/25 9:30:06 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Director Shachar Erez was granted 4,112 shares, increasing direct ownership by 1% to 336,461 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/3/25 9:30:05 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Talkspace Inc.

      SCHEDULE 13G/A - Talkspace, Inc. (0001803901) (Subject)

      5/15/25 5:31:31 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Talkspace Inc.

      10-Q - Talkspace, Inc. (0001803901) (Filer)

      5/9/25 8:38:38 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Talkspace, Inc. (0001803901) (Filer)

      5/6/25 8:15:44 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Leadership Updates

    Live Leadership Updates

    See more
    • Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

      New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

      9/17/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

      Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

      8/28/24 9:06:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Appoints John Mooney as Chief Product Officer

      NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Today Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced the appointment of John Mooney as its new Chief Product Officer, to lead the company's growth initiatives, product strategy and design. Through his work for startup digital health, behavioral health, and diagnostics companies, Mr. Mooney has deep domain expertise in healthcare data, building out platform capabilities and optimizing workflows. "John has spent his career driving innovation for a range of high-growth, high-performing healthcare companies," said Dr. Jon Cohen, Chief Executive Officer, Talkspace. "We look forward to his expertise leveraging dat

      6/5/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care